Status:
UNKNOWN
Feasibility Study of New MRI Protocol in Assessing Early Blood Brain Barrier Disruption (BBBD)in Related to Delay Brain Edema
Lead Sponsor:
Sheba Medical Center
Conditions:
Intra Cerebral Hemorrhage
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
MRI research Group in the Advanced Technology Center of the Sheba Medical Center has developed an innovative methodology based on leakage (extravasation) contrast agent that allows to map the entire b...
Detailed Description
Research's Protocol: Evaluation and Correlation between the disruption in blood-brain-barrier and the development of secondary brain edema associated with brain damage by using MRI in patients with v...
Eligibility Criteria
Inclusion
- Age between 18-80 years.
- patient is able to sign the informed consent form.
- Spontaneous brain hemorrhage ICH in the last12 hours ( pre- admission,or sub- dural bleeding (whether acute or chronic ).
Exclusion
- The patient meets a contraindication to undergo MRI.
- The patient is too unstable to undergo MRI
- The patient is a candidate for surgery within 24 hours.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01830894
Start Date
April 1 2013
End Date
June 1 2014
Last Update
April 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba medical center, Tel Hashomer
Ramat Gan, Israel, 52621